Clinical Trial Update: Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bivalirudin versus heparin in patients with STEMI or NSTEMI on modern antiplatelet therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-segment Elevation Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Angiomax (bivalirudin)
• Unfractionated Heparin (unfractionated heparin)

Snippet

Sponsor: Uppsala University | Conditions: ST-segment Elevation Myocardial Infarction, Non ST-segment Elevation Myocardial Infarction | Phase 4 | Status: COMPLETED